Kesara Na-Bangchang

36PUBLICATIONS
14CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jul 28, 2026
From MyACR to MyμAlbumin: Clinical Validation of a High-Precision, Real-Time Immunoturbidimetric PoC Device for Early Chronic Kidney Disease Detection.

|May 08, 2026
Targeted analysis of KRAS and CREBBP mutations uncovers a potential population-specific signature in thai patients with liver fluke-associated cholangiocarcinoma.

|Jan 22, 2026
Circulating microRNAs Expression as Prognosis Biomarker of Cholangiocarcinoma.

Wanna Chaijaroenkul, Surawut Charoenkajonchai, Nisit Tongsiri

|Jan 22, 2026
A Proteomics and Metabolomics-based Approach to Biomarkers Identification for the Early Diagnosis of Cholangiocarcinoma in a Hamster Model: A Preliminary Study.

Kanyarat Boonprasert, Wanna Chaijaroenkul, Mayuri Tarasuk

|May 13, 2025
Targeting tumor-associated genes, immune response, and circulating tumor cells in intrahepatic cholangiocarcinoma: Therapeutic potential of Atractylodes lancea (Thunb.) DC.

Pongsakorn Martviset, Pathanin Chantree, Nisit Tongsiri

|Apr 28, 2025
The first validation of the Functional Assessment of Cancer Therapy Hepatobiliary (FACT-Hep) for evaluating health-related quality of life (HRQOL) in patients with advanced-stage intrahepatic cholangiocarcinoma (biliary tract cancer).

Teerachat Saeheng, Nisit Tongsiri, Kesara Na-Bangchang

Pageof 6

Frequent Collaborators

4 joint publications

Wanna Chaijaroenkul

3 joint publications

Tullayakorn Plengsuriyakarn

3 joint publications

Nadda Muhamad

3 joint publications

Pongsakorn Martviset